Update 2019
Date: 10/04/2019
Venue: 8/70 Bowral St Bowral , NSW, 2576
Provider: Dr Macken and Associates
Contact: Constantinos Petsoglou, [E] conpetsoglou@hotmail.com, [P] 0450133015
Learning Objectives
- Understand their role and impact of the RANZCO Glaucoma guidelines to the care of patients within the Southern Highlands
- Understand their role and referral recommendations and urgency for patients with ARMD with the Southern Highlands
- understand the indications and postoperative course of patients with new MIGS devices
- be able to identify and outline management of common medical retina conditions as shown on a diagnostic fundus image or OCT scan
- be able to identify features on slit lamp exam of OSSN
- Review management and follow of patients with OSSN including role of optometrists
Max points awarded: 6.00
Session Information
Name |
---|
MIGS & Collaborative Care in Glaucoma |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
Yes |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.50 |
Name |
---|
Collaborative CAre in ARMD & DR |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.50 |
Name |
---|
EyeQ Medical Retina Quiz |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.50 |
Name |
---|
OSSN: Signs and Management |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.50 |
Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
---|---|---|---|---|
MIGS & Collaborative Care in Glaucoma | Face to Face with Assessment | Yes | No | 1.50 |
Collaborative CAre in ARMD & DR | Face to Face with Assessment | No | No | 1.50 |
EyeQ Medical Retina Quiz | Face to Face with Assessment | No | No | 1.50 |
OSSN: Signs and Management | Face to Face with Assessment | No | No | 1.50 |